Acetylcholin esterase inhibitor lignanolide compound and preparation method and application thereof
An acetylcholinesterase and inhibitor technology, which is applied in the directions of drug combinations, pharmaceutical formulations, and medical preparations containing active ingredients, and can solve the problems of restricted application and low oral bioavailability.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0012] Example 14-(4-(3,4-dimethoxybenzyl)-2-carbonyl)tetrahydrofuranmethyl-2-methoxyphenol 2-(N-tert-butoxycarbonyl)amino-4-methylthio Synthesis of alkyl butyrate (ARG1).
[0013] Weigh 0.20g (0.54mmol) arctigenin, 0.27g (1.08mmol) BOC-L-methionine, 0.21g (1.08mmol) 1-ethyl-(3-dimethylaminopropyl) carbodiimide Hydrochloride (EDCI), 0.03g (0.27mmol) 4-dimethylaminopyridine (DMAP) was placed in a 100ml spinner bottle, added 10ml of acetonitrile solution, stirred and dissolved in an ice-water bath, and reacted at room temperature for 1-2 hours, detected by TLC After the reaction was completed, the solvent was evaporated under reduced pressure to obtain a light yellow viscous substance. The viscous material was separated by column chromatography with YMC reversed-phase packing, eluted with acetonitrile / water (55:45) mixed solvent, the required components were collected, the organic solvent was evaporated under reduced pressure, and freeze-dried to obtain a white powder compound ...
Embodiment 2
[0015] Example 24-(4-(3,4-dimethoxybenzyl)-2-carbonyl)tetrahydrofuranmethyl-2-methoxyphenol-2-(N-tert-butoxycarbonyl)amino-3-( Synthesis of 2-indolyl)propionate (ARG2).
[0016] The preparation method is the same as in Example 1, except that Boc-tryptophan is used to obtain compound ARG2.
[0017]
[0018] White solid, 72% yield. 1 H-NMR (CDCl 3 ,300MHz)δ ppm :7.68(1H,d,7.8HZ,C 6 H 5 ),7.39(1H,dd,0.9,8.4HZ,C 6 H 5 ),7.25(1H,dd,0.9,7.2HZ,C 6 H 5 ),7.20(1H,dd,0.9,7.2HZ,C 6 H 5 ),7.14(1H,dd,0.9,8.4HZ,C 6 H 5 ),6.80(1H,d,8.1HZ,C 6 H 5 ),6.64(1H,dd,1.8,8.1HZ,C 6 H 5 ),6.75(1H,d,3.9HZ,C 6 H 5 ),6.84(1H,d,8.1HZ,C 6 H 5 ),6.56(1H,dd,2.1HZ,8.4HZ,C 6 H 5 ),6.51(1H,d,3.9HZ,C 6 H 5 ),5.16(N H ),4.97(m,-NH-C H -COO-),3.93,4.22(m,-COOC H 2 -),3.87(3H,s,OC H 3 ),3.82(3H,s,OC H 3 ),3.73(3H,s,OC H 3 ),3.56,3.45(m,C H 2 ),2.963.03(m,C H 2 ),2.70(m,C H ),2.54,2.63(m,C H 2 ),2.48(m,C H ),1.44(3H,s,C H 3 ).
Embodiment 3
[0019] Example 34-(4-(3,4-dimethoxybenzyl)-2-carbonyl)tetrahydrofuranmethyl-2-methoxyphenol-N-tert-butoxycarbonyl 2-tetrahydropyrrole carboxylate ( Synthesis of ARG3).
[0020] The preparation method is the same as in Example 1, except that Boc-L-proline is used to obtain compound ARG3.
[0021]
[0022] White solid, 65% yield. 1 H-NMR (CDCl 3 ,300MHz)δ ppm :7.04(1H,d,8.1HZ,C 6 H 5 ),6.94(1H,d,7.8HZ,C 6 H 5 ),6.77(1H,d,2.1HZ,C 6 H 5 ),6.70(1H,dd,1.8HZ,8.1HZ,C 6 H 5 ),6.59(1H,dd,1.2HZ,8.4HZ,C6 H 5 ),6.51(1H,d,2.1HZ,C 6 H 5 ),4.52(m,-NH-C H -COO-),3.93,4.16(m,-COOC H 2 -),3.87(3H,s,OC H 3 ),3.84(3H,s,OC H 3 ),3.77(3H,s,OC H 3 ),3.523.67(m,C H 2 ),2.973.00(m,C H 2 ),2.70(m,C H ),2.342.69(m,C H 2 ),2.30(m,C H ),2.16(m,C H 2 ),1.52,1.64(m,C H 2 ),1.49(3H,s,C H 3 ).
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 